E. Ohman J:or Asset Management’s Zimmer Biomet ZBH Stock Holding History

E. Ohman J:or Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$560K	Hold	6,506	–	–	0.01%	396
2026 Q1	$588K	Sell	6,506 -1,544	-19%	-$142K	0.02%	366
2025 Q4	$724K	Sell	8,050 -1,200	-13%	-$114K	0.02%	356
2025 Q3	$911K	Hold	9,250	–	–	0.02%	287
2025 Q2	$844K	Hold	9,250	–	–	0.02%	298
2025 Q1	$1.05M	Sell	9,250 -900	-9%	-$96.3K	0.03%	266
2024 Q4	$1.07M	Buy	10,150 +1,250	+14%	+$134K	0.03%	271
2024 Q3	$961K	Hold	8,900	–	–	0.02%	264
2024 Q2	$966K	Hold	8,900	–	–	0.02%	259
2024 Q1	$1.17M	Buy	8,900 +900	+11%	+$112K	0.03%	228
2023 Q4	$974K	Sell	8,000 -1,600	-17%	-$179K	0.04%	230
2023 Q3	$1.08M	Hold	9,600	–	–	0.04%	222
2023 Q2	$1.4M	Hold	9,600	–	–	0.05%	209
2023 Q1	$1.24M	Buy	9,600 +1,000	+12%	+$126K	0.05%	215
2022 Q4	$1.1M	Hold	8,600	–	–	0.05%	225
2022 Q3	$899K	Sell	8,600 -1,400	-14%	-$154K	0.04%	242
2022 Q2	$1.05M	Hold	10,000	–	–	0.05%	227
2022 Q1	$1.28M	Sell	10,000 -300	-3%	-$36.2K	0.04%	238
2021 Q4	$1.27M	Hold	10,300	–	–	0.04%	261
2021 Q3	$1.46M	Buy	+10,300	New	+$1.52M	0.05%	231
2019 Q4	–	Sell	-5,665	Closed	-$755K	–	483
2019 Q3	$755K	Hold	5,665	–	–	0.05%	202
2019 Q2	$648K	Hold	5,665	–	–	0.04%	213
2019 Q1	$702K	Sell	5,665 -2,884	-34%	-$328K	0.05%	199
2018 Q4	$861K	Sell	8,549 -1,133	-12%	-$127K	0.06%	162
2018 Q3	$1.24M	Buy	9,682 +618	+7%	+$73.5K	0.08%	150
2018 Q2	$981K	Buy	9,064 +3,193	+54%	+$348K	0.07%	158
2018 Q1	$622K	Buy	5,871 +1,236	+27%	+$144K	0.05%	210
2017 Q4	$543K	Sell	4,635 -1,339	-22%	-$151K	0.04%	249
2017 Q3	$679K	Buy	5,974 +206	+4%	+$23.8K	0.06%	206
2017 Q2	$719K	Hold	5,768	–	–	0.07%	192
2017 Q1	$684K	Buy	5,768 +1,442	+33%	+$163K	0.08%	200
2016 Q4	$433K	Hold	4,326	–	–	0.06%	237
2016 Q3	$546K	Buy	4,326 +1,030	+31%	+$127K	0.08%	185
2016 Q2	$385K	Hold	3,296	–	–	0.06%	227
2016 Q1	$341K	Hold	3,296	–	–	0.06%	227
2015 Q4	$328K	Hold	3,296	–	–	0.06%	245
2015 Q3	$301K	Hold	3,296	–	–	0.08%	233
2015 Q2	$350K	Hold	3,296	–	–	0.08%	235
2015 Q1	$376K	Hold	3,296	–	–	0.09%	229
2014 Q4	$367K	Sell	3,296 -1,030	-24%	-$109K	0.09%	232
2014 Q3	$422K	Hold	4,326	–	–	0.1%	197
2014 Q2	$436K	Hold	4,326	–	–	0.11%	194
2014 Q1	$397K	Hold	4,326	–	–	0.1%	217
2013 Q4	$391K	Hold	4,326	–	–	0.09%	223
2013 Q3	$345K	Hold	4,326	–	–	0.09%	248
2013 Q2	$315K	Buy	+4,326	New	+$323K	0.09%	248

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

E. Ohman J:or Asset Management's ZBH Position: Q2 2026 in Review

E. Ohman J:or Asset Management held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 6,506 shares worth $560K. The position accounts for 0.01% of the portfolio, ranked #396.

E. Ohman J:or Asset Management first reported a position in ZBH in Q2 2013 and has held it in 46 quarters since. The position peaked at $1.46M in Q3 2021. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

E. Ohman J:or Asset Management held 6,506 shares of Zimmer Biomet worth $560K as of Q2 2026.
E. Ohman J:or Asset Management left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up 0.01% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #396 holding.
E. Ohman J:or Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 46 quarters since.
E. Ohman J:or Asset Management's Zimmer Biomet position peaked at $1.46M in Q3 2021.
132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.